Peptide GHK-Cu: copper complex chemistry, what the gene expression research actually established, and handling
Reconstituted GHK-Cu turns the solution blue. This is the most common panic message in copper peptide threads, and the answer is that the color is the point. GHK on its own is a colorless tripeptide. The blue comes from the copper (II) ion bound in complex with it, and that complex is the active form. A GHK-Cu solution that reconstitutes clear is worth asking questions about.
The molecule
Glycyl-L-histidyl-L-lysine is a three amino acid sequence that occurs naturally in human plasma, saliva, and urine. Its concentration declines with age, which is the observation most of the aging literature on it is built around. Specific plasma figures circulate widely in community write-ups, usually with unit errors attached, and the primary sources for those numbers are harder to pin down than the citations suggest. The qualitative decline is well established. Treat the exact numbers loosely unless someone puts an original publication in front of you.
Its affinity for copper is comparable to the copper transport site on albumin, which is why it forms the complex readily and why the copper is not an additive but part of the functional unit.
The gene expression literature
According to PubMed, the widely repeated claim that GHK modulates over 4,000 human genes traces to a 2015 review by Pickart, Vasquez-Soltero, and Margolina in BioMed Research International, which describes the peptide as capable of up and downregulating at least 4,000 human genes (DOI). The same group published related reviews in 2014 (DOI) and 2018 (DOI).
Worth knowing before weighing that figure: Loren Pickart founded and runs a company selling copper peptide skincare, and the majority of the review literature on GHK comes from him or his coauthors. That does not make the work wrong. It does mean the body of evidence is unusually concentrated in one commercially interested source, and that is a legitimate thing for a reader to factor in.
The strongest independent result is different in character. Campbell et al. at Boston University and UBC profiled gene expression across lung tissue regions with varying emphysema severity, identified 127 genes tracking with severity, and used the Connectivity Map to search for compounds that would reverse that signature. GHK came out of that search. They then tested it directly on human fibroblasts and found it restored collagen contraction and remodeling in cells from COPD lungs (DOI). That paper was published in Genome Medicine in 2012 and had no connection to the copper peptide industry.
That is a computational screen followed by a cell culture confirmation. It is not a clinical result, and the authors said as much.
Handling
| Condition | Parameter |
|---|---|
| Lyophilized storage | Minus 20 C, dry and dark |
| Reconstituted storage | 2 to 8 C, protected from light |
| Reconstituted window | 2 to 4 weeks |
| Freeze-thaw | Avoid |
Light protection matters more here than for most compounds in the catalog. Copper complexes are photosensitive, and an amber vial or foil wrap is not a precaution anyone regrets.
Allow lyophilized vials to reach room temperature before opening. Cold glass pulls in atmospheric moisture the moment the stopper breaks, and lyophilized powder is hygroscopic.
Solution preparation
Common laboratory practice targets 25 mg/mL, which means 2.0 mL of solvent for a 50 mg vial or 4.0 mL for a 100 mg vial. Vial sizes vary between listings, so check the specific product page rather than assuming.
Add solvent slowly down the interior wall of the vial rather than directly onto the powder. Swirl or roll to dissolve. Do not shake. Foaming denatures peptide at the air liquid interface, and with a copper complex you also risk disrupting the coordination.
Formats
GHK-Cu appears in the catalog as a standalone vial and as a component of two multi compound blends. Component masses within those blends are not published on the product cards, so per compound content in the blends is currently unknown. Full listing is in the pinned catalog index.
Where the evidence stops
Cosmetic and topical formulation studies are the best supported application. Wound healing work in animal models is extensive. The gene expression material is real but sits mostly in review papers from one interested group, with the COPD work as the notable independent exception. Controlled human trials for anything beyond skin appearance endpoints are thin.
References verified against PubMed. PMIDs 26236730, 25302294, 29986520, 22937864, 18644225.
Research use disclaimer: all compounds referenced here are intended for research and laboratory use only. Nothing in this post is intended for human consumption or as medical guidance.
Affiliate disclosure: this community is run by an independent affiliate and is not affiliated with, endorsed by, or operated by American Peptides. Product links in the pinned index are affiliate links, and purchases made through them may earn a commission at no additional cost. Code PROFIT applies the listed discount at checkout.
Posted Aug 31, 2026, 3:02 PM UTC